Clinical Trials
7 trialsNCT06824727 2025-09-05
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
Case Comprehensive Cancer Center
Completed
NCT05053100 2025-05-02
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Mayo Clinic
Completed
NCT05585463 2022-10-20
ACUSAFE2021
Fundació Sant Joan de Déu
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT00001397 2020-10-08
Evaluation, Treatment, and Training for Patients With Blood Disorders
National Institutes of Health Clinical Center (CC)
Completed
NCT00576888 2019-09-16
VAC
Medical College of Wisconsin
Completed